HispanicBusiness

DAYTONA BEACH, FL -- (Marketwire) -- 08/08/12 -- Quture International, Inc. (OTCQB: TCLN) (PINKSHEETS: TCLN) and its operations subsidiary Quture, Inc. ("Quture") announce that its QualOptima product demonstrations are on target with hospital IT leaders' demands and the urgent needs of senior management for healthcare analytics. Quture is in the final stages of return on investment (ROI) evaluations from three hospital reference sites as the Company moves to revenue-based operations and nears completion of the search for its Chief Business Development Officer. Even at its median price point, the market opportunity for QualOptima is in excess of 1.75 billion dollars annually in the United States alone, and exponentially higher with revenue models other than traditional licensing.

In a recent survey from Black Book Rankings released last week, clinical analytics and business intelligence tools are emerging as a top priority for hospital information (IT) leaders. The survey confirms the ROI value proposition of the QualOptima product, which has now been demonstrated to harness real-time medical data to influence fact-based diagnostic and therapeutic decisions at point of care, capture revenues and save costs. According to the survey, eighty-four percent of provider organizations without clinical analytics systems in place currently plan to acquire at least one new or additional clinical analytics tool within twelve months.

Quture's product demonstrations at three key hospitals have been designed to triangulate the QualOptima analytics value proposition. As the operations company moves from development to marketing and sales, the analysis of the return on investment potential of the product is nearing completion from all three sites. Each project provides unique elements for ROI, so that the insight from each converges to attract additional reference hospitals to license QualOptima.

The clinical trial at the University of Miami Miller School of Medicine and Jackson Memorial Hospital (UoM) focused on measuring clinical performance and outcomes. Dr. Keith Candiotti designed the project to demonstrate the value of the product design to ultimately calculate unreimbursed cost relationships with compliance to evidence-based perioperative protocols. The project measures the impact of performance of evidence-based protocols on outcomes and costs. There are significant costs associated with extended stays and complications in recovery and beyond for well-established practice guidelines from professional organizations, for the first time connecting clinical quality with outcomes and costs. Electronic data capture, aggregation into a second generation database, and imposition of quality and value analytics is essential for hospitals that urgently need to move to value-based purchasing and to comply with accreditation standards.

At Niagara Falls Memorial Medical Center (NFMCC), Quture implemented an evidence-based optimal clinical process for prevention of catheter-acquired urinary tract infections (CAUTI) in the intensive care unit. The ROI analysis announced for completion before September is focused on payment initiatives. The clinical demonstration was selected because it is one of the hospital-acquired conditions (HAC) for which providers are no longer reimbursed and is the major patient safety initiative for 2012. Performance measurement based on a nursing-sensitive protocol augments physician performance at the University of Miami for true interdisciplinary performance measurement.